Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.26 USD | +0.48% | +8.66% | +26.73% |
12:21am | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
Apr. 25 | UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.73% | 107B | |
+7.71% | 220B | |
+6.25% | 185B | |
+10.60% | 133B | |
-0.57% | 62.91B | |
+15.42% | 53.34B | |
-1.89% | 47.71B | |
-1.91% | 40.29B | |
+11.16% | 39.57B | |
+6.63% | 26.99B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- RBC Capital Adjusts Price Target on Boston Scientific to $56 From $53, Maintains Outperform Rating